JoelFrancisGradowskiMD

PubMed

• 2 citations
  In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
  Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel F. Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil K. Chandra, Yiwei Liu, Heather L. Mulder, John Easton, ...> ;Blood Advances. 2021 Sep 24
• 8 citations
  SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma
  Jatin S. Gandhi, Fnu Alnoor, Qandeel Sadiq, Jorge Solares, Joel F. Gradowski> ;Pathology, Research and Practice. 2021 Jan 10
• 5 citations
  Follicular Lymphoma Diagnosed in Warthin Tumor: A Case Report and Review of the Literature
  Fnu Alnoor, Jatin S. Gandhi, Matthew K Stein, Joel F. Gradowski> ;Head and Neck Pathology. 2020 Jun 1
• 3 citations
  Prevalence of Lymphoid Neoplasia in a Retrospective Analysis of Warthin Tumor: A Single Institution Experience.
  Fnu Alnoor, Jatin S. Gandhi, Matthew K Stein, Jorge Solares, Joel F. Gradowski> ;Head and Neck Pathology. 2020 Apr 23
• 3 citations
  Hiding in the mantle: mantle cell lymphoma with a mantle zone growth pattern co-occurring with CMV lymphadenitis
  Matthew M. Klairmont, Joel F. Gradowski> ;Blood. 2019 Nov 7
• 6 citations
  Chronic myeloid leukemia, BCR‐ABL1‐positive with CALR and MPL mutations
  Matthew M. Klairmont, Jinjun Cheng, Lee S. Schwartzberg, H. H. Ho, Joel F. Gradowski> ;International Journal of Laboratory Hematology. 2018 Jun 1
• 8 citations
  Recurrent Cytogenetic Abnormalities in Intravascular Large B-Cell Lymphoma.
  Matthew M. Klairmont, Jinjun Cheng, Michael Gary Martin, Joel F. Gradowski> ;American Journal of Clinical Pathology. 2018 May 31
• 3 citations
  AML with MDS-related changes and blasts of mixed lineage: time for a new provisional entity?
  Matthew M. Klairmont, Jinjun Cheng, Joel F. Gradowski> ;Leukemia & Lymphoma. 2018 Apr 4
• 26 citations
  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.
  Joel F. Gradowski, Rachel L. Sargent, Fiona E. Craig, Kathleen Cieply, Kim Fuhrer, Carol Sherer, Steven H. Swerdlow> ;American Journal of Clinical Pathology. 2012 Jul 1
• 16 citations
  Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component
  C. Visco, Sylvia Hoeller, Jeffrey T. Malik, Zijun Y. Xu-Monette, Michele L. Wiggins, Jessica Liu, Warren G. Sanger, Zhongfeng Liu, Julie Chang, Erik A. Ranheim, Joel F...> ;The American Journal of Surgical Pathology. 2011 Feb 1
• 35 citations
  Follicular lymphomas with plasmacytic differentiation include two subtypes
  Joel F. Gradowski, Elaine S. Jaffe, Roger A. Warnke, Stefania Pittaluga, Urvashi Surti, Leena A Gole, Steven H. Swerdlow> ;Modern Pathology. 2010 Jan 1
• 8 citations
  Sudden loss of vision: Purtscher retinopathy in multiple myeloma
  Amit Nautiyal, G. Amescua, Angus Jameson, Joel F. Gradowski, Feiyu Hong, Bernard H. Doft> ;CMAJ. 2009 Dec 8
• 4 citations
  Mycobacterium kansasii infection diagnosed by pleural fluid cytology: a case report.
  Akosua B. Domfeh, Laurentia Nodit, Joel F. Gradowski, Sheldon I. Bastacky> ;Acta Cytologica. 2007 Jul 1
• 6 citations
  Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
  Joel F. Gradowski, Geeta S. Mantha, Jennifer L. Hunt, Sanja Dacic> ;Diagnostic Molecular Pathology. 2007 Jun 1
• 18 citations
  Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans.
  Barbara P. Schick, Joel F. Gradowski, James D. San Antonio, Jose Martinez> ;Thrombosis and Haemostasis. 2001 Mar 1
• 76 citations
  Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells
  Barbara P. Schick, Joel F. Gradowski, James D. San Antonio> ;Blood. 2001 Jan 15
• Join now to see all